Is SARS-CoV-2 important for multiple sclerosis?

被引：0
|
作者：
Chyzhyk, V. [1 ]
Sialitski, M.
Boika, A. [1 ]
Bahamaz, V.
Mazurenka, K. [1 ]
Ponomarev, V. [1 ]
机构：
[1] Dept Neurol & Neurosurg, Minsk, BELARUS
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-084
引用
收藏
页码：492 / 492
页数：1
相关论文
共 50 条
  • [21] Multiple sclerosis as a model to investigate SARS-CoV-2 effect on brain atrophy
    Rebsamen, Michael
    Friedli, Christoph
    Radojewski, Piotr
    Diem, Lara
    Chan, Andrew
    Wiest, Roland
    Salmen, Anke
    Rummel, Christian
    Hoepner, Robert
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (02) : 538 - 543
  • [22] Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis
    Gibson, Elena G.
    Pender, Melissa
    Angerbauer, Michael
    Cook, Craig
    Jones, Barbara
    Spivak, Adam M.
    Spivak, Emily S.
    Swaminathan, Sankar
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (07):
  • [23] SARS-COV-2 pandemic lockdown: perceived consequences on multiple sclerosis patients
    Sartori, A.
    Dinoto, A.
    Pasquin, F.
    Bratina, A.
    Bosco, A.
    Manganotti, P.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 105 - 105
  • [24] A Case of Multiple Sclerosis Uncovered Following Moderna SARS-CoV-2 Vaccination
    Mele, Ange Ahoussougbemey
    Ogbuagu, Henry
    Parag, Sahil
    Pierce, Bradley
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [25] SEROLOGICAL RESPONSE TO SARS-COV-2 VACCINES IN PATIENTS WITH MULTIPLE SCLEROSIS IN ARGENTINA
    Roja, Juan i.
    Alonso, Ricardo
    Cabrera, Mariela
    Contentti, Edgar carnero
    Cristiano, Edgardo
    Deri, Norma
    Hryb, Javier
    Lopez, Pablo
    Luetic, Geraldine
    Patrucco, Liliana
    Tkachuk, Veronica
    Ysrraelit, Maria c.
    Zanga, Gisela
    Cruces, Leonel
    Turk, Gabriel
    Longueira, Yesica
    Laufer, Natalia
    Nunez, Sebastian
    MEDICINA-BUENOS AIRES, 2023, 83 (03) : 358 - 365
  • [26] Controversies in neuroimmunology: multiple sclerosis, vaccination, SARS-CoV-2 and other dilemas
    Reyes-Nino, Saul
    Eduardo Rodriguez-Orozco, Jaime
    Georges Moutran-Barroso, Habib
    Kreinter-Rosembaun, Hellen
    Gaviria-Carrillo, Mariana
    Salej-Duran, Vanessa
    Mancera-Charry, Julian
    Claudia Villegas, Ana
    Cuellar-Giraldo, David
    Sebastian Torres-Sandoval, Juan
    Gomez-Mazuera, Angela
    Duque-Samper, Aristides
    Toro-Gomez, Jaime
    BIOMEDICA, 2022, 42 : 78 - 99
  • [27] Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection
    Pignolo, Antonia
    Aprile, Maria
    Gagliardo, Cesare
    Giammanco, Giovanni Maurizio
    D'Amelio, Marco
    Aridon, Paolo
    La Tona, Giuseppe
    Salemi, Giuseppe
    Ragonese, Paolo
    NEUROLOGY INTERNATIONAL, 2021, 13 (04) : 695 - 700
  • [28] Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg
    Capasso, Nicola
    Palladino, Raffaele
    Montella, Emma
    Pennino, Francesca
    Lanzillo, Roberta
    Carotenuto, Antonio
    Petracca, Maria
    Iodice, Rosa
    Iovino, Aniello
    Aruta, Francesco
    Pastore, Viviana
    Buonomo, Antonio Riccardo
    Zappulo, Emanuela
    Gentile, Ivan
    Triassi, Maria
    Morra, Vincenzo Brescia
    Moccia, Marcello
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) : 1 - 11
  • [29] Prevalence of SARS-CoV-2 antibodies in multiple sclerosis: The hidden part of the iceberg
    Capasso, Nicola
    Palladino, Raffaele
    Montella, Emma
    Pennino, Francesca
    Lanzillo, Roberta
    Carotenuto, Antonio
    Petracca, Maria
    Iodice, Rosa
    Iovino, Aniello
    Aruta, Francesco
    Pastore, Viviana
    Buonomo, Antonio Riccardo
    Zappulo, Emanuela
    Gentile, Ivan
    Triassi, Maria
    Morra, Vincenzo Brescia
    Moccia, Marcello
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [30] Background immunity: How important is it for SARS-CoV-2?
    Silva Junior, Jose Valter Joaquim
    Lopes, Thaisa Regina Rocha
    Weiblen, Rudi
    Flores, Eduardo Furtado
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1253 - 1254
12345